NCT06283511View on ClinicalTrials.gov

Evaluation of the RESTART Survival Programme

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2026

Conditions
Invasive Breast Cancer
Interventions
OTHER

educational workshops

patient will be proposed to assist to educational workshops + the possibility to assist to a physical rehabilitation programme

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER

NCT06283511 - Evaluation of the RESTART Survival Programme | Biotech Hunter | Biotech Hunter